Flatiron Health Reaches a Major Milestone in Research Publications
In an impressive demonstration of growth and influence, Flatiron Health has surpassed a key milestone, achieving over 1,000 research publications that utilize its extensive electronic health record-derived real-world data (RWD). This accomplishment cements Flatiron's role as a leader in the integration of RWD into cancer research and care, underlining its commitment to improving patient outcomes through evidence-based approaches.
The Impact of Real-World Data on Research
Since its inception in 2012, Flatiron Health has transformed the way RWD and real-world evidence (RWE) are applied in clinical settings. This comprehensive database, which is gleaned from routine patient care, has been pivotal in generating actionable insights that shape treatment paradigms and regulatory decisions. By focusing on patient experiences, Flatiron strives to enhance and extend lives, ensuring that insights from every individual diagnosed with cancer contribute significantly to the broader understanding of the disease.
Collaboration with Key Stakeholders
Flatiron Health's success is not achieved in isolation. The company has collaborated extensively with over 20 global leaders in oncology therapeutics, esteemed academic institutions, regulatory bodies, and policy organizations. Working in partnership with these entities, Flatiron has been able to fuel numerous rigorous research projects, which has propelled its data's credibility and utility in real-world applications.
Notable Publications and Contributions to Oncology
Flatiron’s research efforts have significantly enriched the field of oncology. Publications emerging from Flatiron have contributed to notable advancements in both common and rare cancers. With an extensive array of findings impacting the National Cancer Institute’s recognized cancer types, Flatiron researchers have not only advanced scientific knowledge but also informed clinical practice worldwide.
The breadth of this body of work is reflected in its presence across 142 unique peer-reviewed journals and hundreds of presentations at prestigious scientific gatherings, such as the American Society of Clinical Oncology (ASCO) annual meetings. This visibility underscores the importance placed on real-world insights by the oncology community.
Driving Regulatory and Clinical Insight
Flatiron’s insights from RWD have been foundational in shaping treatments and guidelines. Their publications have sparked crucial conversations on subjects like expanded therapy options for specific cancer populations, guided dosing regimens, and timelines for discontinuation of certain therapies. These contributions have proven essential in navigating the complex landscape of cancer treatment while prioritizing patient welfare.
Innovations in Data Utilization
The innovative spirit at Flatiron extends beyond publishing findings. The company has pioneered new methodologies that leverage artificial intelligence for extracting meaningful data from unstructured sources. This includes real-world endpoints that could previously not be efficiently measured.
Moreover, Flatiron’s recent development of AI-enhanced Panoramic datasets represents a significant leap forward. This new approach offers unprecedented access to over 4 million de-identified patient records and 1.5 billion data points, allowing researchers to analyze patient journeys comprehensively. Such data not only facilitates research on emerging therapies but also enhances understanding of patient experiences across treatment landscapes.
Commitment to Transforming Cancer Care
Flatiron Health’s mission to enhance cancer care through innovative solutions and high-quality data is unwavering. As an independent affiliate of the Roche Group, the company remains dedicated to pushing the boundaries of what is possible in oncology. Through continuous advancements in machine learning and RWE applications, Flatiron is shaping a modern, connected healthcare ecosystem that benefits every cancer patient.
Frequently Asked Questions
What is the primary focus of Flatiron Health?
Flatiron Health focuses on transforming cancer care through real-world data and evidence, aiming to improve patient outcomes and advance research in oncology.
How many research publications has Flatiron Health achieved?
Flatiron Health has achieved over 1,000 research publications using its high-quality real-world data.
What role does collaboration play in Flatiron's research?
Collaboration with top oncology developers, academic institutions, and regulatory bodies is critical for Flatiron to conduct rigorous research and enhance data credibility.
What innovations has Flatiron introduced in cancer research?
Flatiron has innovated in the use of artificial intelligence to extract biomarkers from unstructured data and has launched Panoramic datasets for extensive analysis.
How does Flatiron Health influence cancer care practices?
Flatiron's research influences cancer care by providing insights that shape treatment guidelines, inform policy decisions, and enhance the understanding of patient experiences.
